Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials

Br J Clin Pharmacol. 2022 Jun;88(6):2657-2664. doi: 10.1111/bcp.15219. Epub 2022 Jan 27.

Abstract

Methaemoglobin results from the oxidation of ferrous to ferric iron in the centre of the haem moiety of haemoglobin. The production of dose-dependent methaemoglobinaemia by 8-aminoquinoline antimalarial drugs appears to be associated with, but is not directly linked to, therapeutic efficacy against latent Plasmodium vivax and Plasmodium ovale malarias (radical cure). Iatrogenic methaemoglobinaemia may be a useful pharmacodynamic measure in 8-aminoquinoline drug and dose optimization.

Keywords: 8-aminoquinolines; Plasmodium vivax; methaemoglobinaemia; primaquine; tafenoquine.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoquinolines / adverse effects
  • Antimalarials* / therapeutic use
  • Humans
  • Methemoglobinemia* / chemically induced
  • Methemoglobinemia* / drug therapy
  • Plasmodium vivax

Substances

  • Aminoquinolines
  • Antimalarials
  • 8-aminoquinoline